Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M52,540Revenue $M6,300Net Margin (%)19.1Z-Score9.8
Enterprise Value $M50,985EPS $3.3Operating Margin %28.7F-Score7
P/E(ttm))41.6Cash Flow Per Share $4.6Pre-tax Margin (%)27.2Higher ROA y-yY
Price/Book7.810-y EBITDA Growth Rate %15.5Quick Ratio3.8Cash flow > EarningsY
Price/Sales7.95-y EBITDA Growth Rate %27.6Current Ratio4.1Lower Leverage y-yY
Price/Cash Flow20.1y-y EBITDA Growth Rate %10.9ROA % (ttm)12.4Higher Current Ratio y-yN
Dividend Yield %0.1Insider Buy (3m)0ROE % (ttm)20.3Less Shares Outstanding y-yN
Payout Ratio %5.0Shares Outstanding M298ROI % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNRichard Perry 2014-06-30 Buy 7.8%$116.63 - $173.95
($155.63)
$ 178.415%New holding, 1667625 sh.1,667,625
AGNJohn Paulson 2014-06-30 Buy 4.1%$116.63 - $173.95
($155.63)
$ 178.415%New holding, 5602000 sh.5,602,000
AGNJean-Marie Eveillard 2014-06-30 Buy 0.01%$116.63 - $173.95
($155.63)
$ 178.415%New holding, 30000 sh.30,000
AGNRay Dalio 2014-06-30 Sold Out -0.02%$116.63 - $173.95
($155.63)
$ 178.415%Sold Out0
AGNGeorge Soros 2014-03-31 Sold Out -0.09%$110.28 - $131.43
($121.38)
$ 178.447%Sold Out0
AGNJoel Greenblatt 2014-03-31 Reduce-0.04%$110.28 - $131.43
($121.38)
$ 178.447%Reduce -46%18,843
AGNRay Dalio 2014-03-31 Reduce-0.02%$110.28 - $131.43
($121.38)
$ 178.447%Reduce -54.57%18,499
AGNFrank Sands 2013-12-31 Sold Out -1.9%$88.48 - $110.85
($95.35)
$ 178.487%Sold Out0
AGNRay Dalio 2013-12-31 Reduce-0.14%$88.48 - $110.85
($95.35)
$ 178.487%Reduce -81.99%40,719
AGNJoel Greenblatt 2013-12-31 Reduce-0.09%$88.48 - $110.85
($95.35)
$ 178.487%Reduce -45.01%34,897
AGNJoel Greenblatt 2013-09-30 Add0.1%$84.24 - $92.63
($89.85)
$ 178.499%Add 113.74%63,459
AGNGeorge Soros 2013-09-30 Buy 0.07%$84.24 - $92.63
($89.85)
$ 178.499%New holding, 75000 sh.75,000
AGNFrank Sands 2013-09-30 Reduce-0.61%$84.24 - $92.63
($89.85)
$ 178.499%Reduce -22.67%7,422,715
AGNRay Dalio 2013-06-30 Add0.17%$81.99 - $116.17
($103.71)
$ 178.472%Add 2759.74%249,341
AGNJoel Greenblatt 2013-06-30 Add0.1%$81.99 - $116.17
($103.71)
$ 178.472%Add 722.89%29,690
AGNFrank Sands 2013-06-30 Reduce-1.27%$81.99 - $116.17
($103.71)
$ 178.472%Reduce -24.86%9,598,964
AGNFrank Sands 2013-03-31 Add0.35%$91.73 - $111.89
($106.54)
$ 178.467%Add 7.38%12,774,895
AGNRay Dalio 2013-03-31 Reduce-0.12%$91.73 - $111.89
($106.54)
$ 178.467%Reduce -93.77%8,719
AGNJoel Greenblatt 2013-03-31 Reduce-0.08%$91.73 - $111.89
($106.54)
$ 178.467%Reduce -81.38%3,608
AGNFrank Sands 2012-12-31 Add0.72%$87.95 - $95.26
($91.85)
$ 178.494%Add 19.46%11,896,641
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AGN John Paulson 2014-06-305,602,0001.884.1New Buy
AGN Jean-Marie Eveillard 2014-06-3030,0000.010.01New Buy
AGN Richard Perry 2014-06-301,667,6250.567.8New Buy
AGN Mario Gabelli 2014-06-30131,1980.040.12+3.37%
AGN Dodge & Cox 2014-06-303,56400
AGN Joel Greenblatt 2014-06-3016,2810.010.03-13.6%
AGN Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8215.52view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.743.2view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7943.1view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3542.46view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6642.11view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3942.42view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7443.15view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.444.69view
PYOTT DAVID E IChairman of the Board and CEO 2014-02-12Sell252,000$123.1246.2view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5245.73view

Press Releases about AGN :

    Quarterly/Annual Reports about AGN:

    News about AGN:

    Articles On GuruFocus.com
    A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
    These 6 Top Dividend Stocks Starting To Take Off Sep 09 2014 
    Allergan: A ROE That Has Returned to Acceptable Levels Sep 07 2014 
    George Soros Reveals His Largest Stake Jul 23 2014 
    Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal Apr 25 2014 
    Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen Apr 23 2014 
    Bill Ackman Presentation - Perspective from Allergan's Largest Shareholder Apr 23 2014 
    Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
    Abbott Capturing Incremental Market Share Mar 18 2014 
    Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Alle Feb 16 2014 


    More From Other Websites
    Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance Sep 29 2014
    Where the Allergan-Valeant(-Salix-Actavis-Teva) Fights Stand Now Sep 29 2014
    Dealpolitik: Shareholders May Have Little Influence on Allergan Decision Sep 29 2014
    ALLERGAN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 29 2014
    Allergan Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone intravitreal... Sep 29 2014
    [$$] Allergan Reiterates Opposition to Valeant Bid Sep 29 2014
    Allergan Board of Directors Issues Statement Sep 29 2014
    6:27 am Allergan: Jackson Square Partners sent letter; 'feel obligated to publicly raise our... Sep 29 2014
    Drugs groups trapped in tangled M&A web Sep 28 2014
    Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix Sep 28 2014
    Jackson Square Joins Allergan Investors Against Salix Bid Sep 27 2014
    Major Allergan Investor Joins Chorus Against Salix Deal Sep 27 2014
    Shareholder T. Rowe Pirce urges Allergan to hold off on deals Sep 27 2014
    [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote Sep 26 2014
    Why Allergan (AGN) Stock Is Declining in After-Hours Trading Today Sep 26 2014
    T. Rowe joins concerns over Allergan governance Sep 26 2014
    Shareholder T. Rowe Price urges Allergan to hold off on deals Sep 26 2014
    Allergan Shareholder T. Rowe Price Criticizes Board Sep 26 2014
    Allergan Writes Back, Coaxes Shareholders Against Valeant Sep 26 2014
    T. Rowe Price urges Allergan to drop Salix bid Sep 26 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK